Schroder Investment Management Group
BRLI

Schroder Investment Management Group’s BIO-REFERENCE LABS INC-NEW- BRLI Stock Holding History

Schroder Investment Management Group’s Portfolio BRLI Stock Details BRLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-6,000
Closed -$166K – 1493
2014
Q1 		$166K Sell
6,000
-403,600
-99% -$10.6M ﹤0.01% 1186
2013
Q4 		$10.5M Sell
409,600
-53,000
-11% -$1.63M 0.01% 636
2013
Q3 		$13.8M Sell
462,600
-64,600
-12% -$1.8M 0.03% 546
2013
Q2 		$15.2M Buy
+527,200
New +$14.5M 0.04% 484

Other funds holding BRLI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
EIP
Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
MRM
Michael R. Murphy $255M AUM 0.87% 1-Year Est. Return
Tiger Global Management
Tiger Global Management New York $22.8B AUM 30.07% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Schroder Investment Management Group's BRLI Position: Q2 2014 in Review

Schroder Investment Management Group sold out of BIO-REFERENCE LABS INC-NEW- (BRLI) in Q2 2014, closing a stake of 6,000 shares — an estimated $166K sold.

Schroder Investment Management Group first reported a position in BRLI in Q2 2013 and held it in 4 quarters. The position peaked at $15.2M in Q2 2013. 168 funds tracked by Wall St. Rank hold BRLI as of Q2 2014.

  • Schroder Investment Management Group reported no remaining BIO-REFERENCE LABS INC-NEW- position as of Q2 2014 after selling out during the quarter.
  • Schroder Investment Management Group sold 6,000 BIO-REFERENCE LABS INC-NEW- shares in Q2 2014, an estimated $166K.
  • Schroder Investment Management Group first reported a position in BIO-REFERENCE LABS INC-NEW- in Q2 2013 and held it in 4 quarters.
  • Schroder Investment Management Group's BIO-REFERENCE LABS INC-NEW- position peaked at $15.2M in Q2 2013.
  • 168 funds tracked by Wall St. Rank held BIO-REFERENCE LABS INC-NEW- as of Q2 2014.

Based on Schroder Investment Management Group's 13F filing for Q2 2014, filed 13 Aug 2014.